Epetraborole

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameEpetraborole
Drug Alias Name盐酸依培保洛Epetraborolum盐酸依培硼罗Epetraborole HydrochlorideEpetraborol +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionLeucyl-tRNA synthetase inhibitors
TargetsLeucyl-tRNA synthetase
Therapy Area/IndicationsPulmonary Mycobacterium abscessus InfectionRenal InsufficiencyLung Diseases +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAN2 Therapeutics IncBrii Biosciences Inc
Inactive CompaniesGlaxosmithkline PlcPfizer IncFudan University
Active IndicationsPulmonary Mycobacterium abscessus InfectionRenal InsufficiencyTuberculosis, Multidrug-Resistant
Inactive IndicationsLung DiseasesBreast NeoplasmsUrinary Tract Infections +[7] 

Other Information

ATC CodeN/A
Related LinksN/A